AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820

Expensive Performer

8725.00 426.00 (5.13%)

New 52W Low in past week

56,853

NSE+BSE Volume

High volume+gain today

NSE 13 Apr, 2026 3:31 PM (IST)

CDSCO Approval

Astrazeneca gets CDSCO approval to market Acalabrutinib tablets with market size of $3.8 bn in 2025 See details

Detailed Stock Analysis for AstraZeneca Pharma with Real-time Stock Report

Download Sample Report